Pharmaceutical Industry Information Portal

HomeNews

News

Catalent Plans Multi-Phase, $100 Million Expansion of Italian Facility

Catalent’s Anagni site is a world-class biologics and oral dose manufacturing facility that specializes in late-stage and commercial product launches.

Appeal supported FAS in case of orthopedic products cartel

The FAS Russia has sent the case materials to law enforcements for making a decision on initiating criminal cases against company officials.

Sputnik V vaccine approved for use in Chile

Thus Sputnik V is now approved in 69 countries with total population exceeding 3.7 billion people - nearly half of the global population.

EAEU GMP Certificate issued to Pharmasyntez

The Pharmasyntez Group of Companies also was one of the first in Russia to be granted a Marketing Authorization under the EAEU rules.

Thermo Fisher Scientific Opens cGMP Plasmid DNA Manufacturing Facility

The 67,000-square-foot facility, located on Thermo Fisher's Carlsbad campus, is part of an investment strategy to ensure customers can reliably meet growing global demand for cell and gene therapies and vaccines.

Sputnik V vaccine against coronavirus authorized in Nigeria

Total population of all countries where Sputnik V is approved for use now exceeds 3.7 billion people, which is nearly half of the global population.
spot_img

Expert Articles

spot_img